Signia Circular Stapler for Rectal Disease
(SECURE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the safety and effectiveness of a new surgical tool, the Signia circular stapler, in patients undergoing specific types of bowel surgery. It focuses on procedures involving the left side of the colon or the rectum, where a section is removed and the remaining ends are joined. Prospective participants should plan to have this type of elective surgery and agree to use the Signia tool during the operation. As an unphased trial, this study offers patients the chance to contribute to innovative surgical advancements.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulant treatment, it must be reversed, and you should not have had chemotherapy or biologics within 6 weeks before the procedure.
What prior data suggests that the Signia Circular Stapler is safe for rectal disease procedures?
Research shows that the Signia Circular Stapler with Tri-Staple Technology creates strong connections in the colon or rectum during surgery. Studies have found that this triple-layered stapler withstands significant pressure without breaking, potentially reducing leaks at the tissue junction.
One study highlighted that Tri-Staple Technology reduces leaks, the need for additional surgeries, and severe complications. These findings suggest that the stapler is generally safe and may offer increased safety for patients undergoing these surgeries.
Since this stapler is already approved for surgical use, it has been found safe for patients. However, like any medical procedure, risks exist, so discussing them with a healthcare professional is important.12345Why are researchers excited about this trial?
The Signia Circular Stapler with Tri-Staple Technology is unique because it offers a more sophisticated approach to creating an anastomosis during colorectal surgeries. Unlike traditional staplers, which typically use uniform staples, the Tri-Staple Technology employs variable height staples, which can provide more flexibility and potentially better tissue compression. This can lead to improved healing and reduced risk of complications, which is why researchers are excited about its potential benefits over existing surgical stapling methods.
What evidence suggests that the Signia Circular Stapler is effective for rectal disease?
Research shows that the Signia Circular Stapler with Tri-Staple Technology holds promise for rectal surgeries. Studies have found that this stapler creates very strong surgical connections, potentially reducing the risk of leaks. Since leaks are a common surgical issue, minimizing them is crucial. The Tri-Staple technology also decreases the likelihood of additional surgeries and serious complications. Overall, the stapler aims to enhance surgical outcomes by providing strong, reliable connections.23456
Who Is on the Research Team?
Katharine Louise Jackson, MD, FACS, MBBS, MA
Principal Investigator
Duke Raleigh Hospital
John Monson, MD, FACS
Principal Investigator
Northwell Health
Are You a Good Fit for This Trial?
This trial is for patients undergoing left-sided colon, sigmoid, or rectal resections. Specific conditions include intestinal diseases, colorectal anastomosis issues, and rectal cancer among others. Details on inclusion and exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo left-sided colon, sigmoid, or rectal resections using the Signia™ circular stapler
Postoperative Monitoring
Participants are monitored for safety and performance outcomes, including incidence of anastomotic leaks and device-related adverse events
Extended Follow-up
Further monitoring for safety and performance outcomes, including readmission and adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Signia Circular Stapler with Tri-Staple Technology
Trial Overview
The study evaluates the safety and performance of the Signia™ circular stapler with Tri-Staple™ Technology in surgeries for certain lower gastrointestinal tract conditions.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
single arm study, no control arm
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medtronic - MITG
Lead Sponsor
Geoff Martha
Medtronic - MITG
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. John Doe
Medtronic - MITG
Chief Medical Officer since 2023
MD from Harvard Medical School
Citations
Clinical impact of the triple‐layered circular stapler for ...
Anastomoses created using a triple‐layered circular stapler had high bursting pressure, which might contribute to a lower incidence of anastomotic leakage ...
Signia™ Circular Stapler with Tri-Staple™ Technology
A circular stapler that combines Signia™ intelligence, Adaptive Compression™ technology, and Tri-Staple™ reloads to empower anastomotic performance.
3.
ctv.veeva.com
ctv.veeva.com/study/post-market-study-of-the-signia-circular-stapler-with-tri-staple-technology-in-left-sided-colon-sigPost-Market Study of the Signia Circular Stapler With Tri ...
The primary objective of this study is to evaluate the safety and performance of the Signia™ circular stapler, for the creation of anastomoses ...
Does Tri‐Staple™ technology reduce the risk of ...
This study demonstrates the potential clinical benefits of Tri-Staple™ technology in reducing anastomotic leakage, reoperations, and severe ...
5.
medtronic.com
medtronic.com/content/dam/medtronic-wide/public/united-states/products/surgical-stapling/signia-circular-stapler-information-sheet.pdfSignia™ circular stapler with Tri-Staple™ technology
Results may not correlate with clinical performance in humans. ¶ Compared to manual clamping circular staplers, p. < 0.001, n = 5 for SIGCIR, n = 9 for TriEEA.
Post-Market Study of the Signia Circular Stapler With Tri- ...
The primary objective of this study is to evaluate the safety and performance of the Signia™ circular stapler, for the creation of anastomoses ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.